Burden of Long-Term Morbidity Borne by Survivors of Acute Myeloid Leukemia Treated With Blood or Marrow Transplantation: The Results of the BMT Survivor Study.
Armenian SH, Chen Y, Hageman L, Wu J, Landier W, Bosworth A, Francisco L, Schlichting E, Bhatia R, Salzman D, Wong FL, Weisdorf DJ, Forman SJ, Arora M, Bhatia S.
Armenian SH, et al.
J Clin Oncol. 2022 Oct 1;40(28):3278-3288. doi: 10.1200/JCO.21.02829. Epub 2022 Jun 22.
J Clin Oncol. 2022.
PMID: 35731989
Free PMC article.
The most prevalent conditions included subsequent neoplasms, diabetes, cataracts, venous thromboembolism, and joint replacement. Survivors were more likely to report poor general health (odds ratio [OR], 3.8; 95% CI, 2.8 to 5.1), activity limitation (O …
The most prevalent conditions included subsequent neoplasms, diabetes, cataracts, venous thromboembolism, and joint replacemen …